Missouri Trust & Investment CO Biogen Inc. Transaction History

Missouri Trust & Investment CO

$264 Million
Q2 2024

A detailed history of Missouri Trust & Investment CO transactions in Biogen Inc. stock. As of the latest transaction made, Missouri Trust & Investment CO holds 3,882 shares of BIIB stock, worth $759,435. This represents 0.34% of its overall portfolio holdings.

Number of Shares

3,882

Previous 3,832 1.3%

Holding current value

$759,435

Previous $826,000 8.84%

% of portfolio

0.34%

Previous 0.32%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $9,526 - $11,836	50 Added 1.3%	3,882 $899,000
Q1 2024 May 13, 2024	BUY	$212.02 - $267.71 $78,447 - $99,052	370 Added 10.69%	3,832 $826,000
Q4 2023 Feb 08, 2024	SELL	$222.59 - $267.94 $46,743 - $56,267	-210 Reduced 5.72%	3,462 $895,000
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $310,292 - $350,215	1,225 Added 50.06%	3,672 $943,000
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $49,545 - $57,250	180 Added 7.94%	2,447 $697,000
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $100,058 - $114,012	-390 Reduced 14.68%	2,267 $630,000
Q4 2022 Feb 10, 2023	SELL	$252.44 - $306.72 $504 - $613	-2 Reduced 0.08%	2,657 $736,000
Q3 2022 Nov 10, 2022	SELL	$194.69 - $268.46 $43,999 - $60,671	-226 Reduced 7.83%	2,659 $710,000
Q2 2022 Aug 10, 2022	BUY	$187.54 - $223.02 $48,760 - $57,985	260 Added 9.9%	2,885 $588,000
Q1 2022 May 10, 2022	BUY	$193.77 - $244.14 $98,822 - $124,511	510 Added 24.11%	2,625 $553,000
Q4 2021 Feb 02, 2022	BUY	$223.92 - $287.77 $473,590 - $608,633	2,115 New	2,115 $507,000

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Missouri Trust & Investment CO, based on Form 13F filings with the SEC.

News

Stay updated on Missouri Trust & Investment CO with notifications on news.

Account

Missouri Trust & Investment CO Biogen Inc. Transaction History